ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Samuel Broder Plans To Leave Celera.

September 10, 2010

Mass. Passes Tobacco Tax, ACS Lauds Victory Over Cigarette Industry

November 20, 1992